Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect
Open accessThe DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
The regulation of HSC proliferation and engraftment of the BM is an important but poorly understood process, particularly during ontogeny. Here we show that in mice, all HSCs are cycling until 3 weeks after birth. Then, within 1 week, most became quiescent. Prior to 4 weeks of age, the proliferating HSCs with long-term multilineage repopulating activity displayed an engraftment defect when transiting S/G2/M. During these cell cycle phases, their expression of CXC chemokine ligand 12 (CXCL12; also referred to as stromal cell-derived factor 1 [SDF-1]) transiently increased. The defective engrafting activity of HSCs in S/G2/M was reversed when cells were allowed to progress into G1 prior to injection or when the hosts (but not the cells) were pretreated with a CXCL12 antagonist. Interestingly, the enhancing effect of CXCL12 antagonist pretreatment was exclusive to transplants of long-term multilineage repopulating HSCs in S/G2/M. These results demonstrate what we believe to be a new HSC regulatory checkpoint during development. They also suggest an ability of HSCs to express CXCL12 in a fashion that changes with cell cycle progression and is associated with a defective engraftment that can be overcome by in vivo administration of a CXCL12 antagonist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“HSCs isolated from the fetal liver (FL-HSCs) at embryonic day 14.5 (E14.5), a developmental time at which HSCs are known to be highly cycling (Bowie et al., 2006; Morrison et al., 1995; Nygren et al., 2006; Pietras et al., 2011)”
From Quiescent Hematopoietic Stem Cells Accumulate DNA Damage during Aging that Is Repaired upon Entry into Cell Cycle (2014) · cites this paper as Bowie et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“mined as previously described (76), and the housekeeping Gapdh gene tran-”
MethodMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140 · cited 8×
“Gene expression analysis of the G 1 and S/G 2 /M subsets of highly purified lin – Sca1 + CD43 + Mac1 + HSCs from 14.5-dpc FL and 3-wk BM. Gene expression in G 1 was set as 1, and the fold change in transcript levels in the corresponding S/G 2 /M fraction is shown.”
BackgroundInfluentialBmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.
Park, I.-K., Qian, D., Kiel, M., Becker, M. W., Pihalja, M., Weissman, I. L., Morrison, S. J., & Clarke, M. F. (2003) · Nature · doi:10.1038/nature01587 · Cited by 1,871 · cited 1×
“These include genes encoding various transcription factors, i.e., Runx1 (55), Notch (56), Scl (57), bmi1 (58, 59), and Gfi-1 (60, 61), as well as the growth factor receptors c-Kit (62, 63) and Tie2 (64).”
BackgroundDependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., et al. (1999) · Science · doi:10.1126/science.283.5403.845 · Cited by 1,644 · cited 1×
“…be predicted from the explanation we have advanced, forced overexpression of CXCR4 in retrovirally transduced (i.e., proliferating) human HSCs was able to enhance the in vivo engrafting activity of these cells (68), and, conversely, treatment with antibodies to CXCR4 had the opposite effect (69).”
BackgroundBmi-1 determines the proliferative capacity of normal and leukaemic stem cells.
Lessard, J., & Sauvageau, G. (2003) · Nature · doi:10.1038/nature01572 · Cited by 1,452 · cited 1×
“, Runx1 (55), Notch (56), Scl (57), bmi1 (58, 59), and Gfi-1 (60, 61), as well as the growth factor receptors c-Kit (62, 63) and Tie2 (64).”
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4
Petit, I., Szyper-Kravitz, M., Nagler, A., Lahav, M., Peled, A., Habler, L., Ponomaryov, T., Taichman, R. S., Arenzana-Seisdedos, F., Fujii, N., et al. (2002) · Nature Immunology · doi:10.1038/ni813 · Cited by 1,332 · cited 1×
“However, CXCL12 levels in the BM are also subject to regulation, as occurs, for example, following the administration of G-CSF (70).”
BackgroundDenhardt, D. T., Noda, M., O’Regan, A. W., Pavlin, D., & Berman, J. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12980 · Cited by 1,059
How do stem cells find their way home?
Lapidot, T., Dar, A., & Kollet, O. (2005) · Blood · doi:10.1182/blood-2005-04-1417 · Cited by 985 · cited 1×
“Previous work has suggested that the ability of transplanted HSCs to reach a niche within the BM that can support their self maintenance may depend on the strength of the CXCL12 gradient they encounter within the BM space, causing them to migrate toward the osteoblasts that line the bone (22).”
BackgroundBroxmeyer, H. E., Orschell, C. M., Clapp, D. W., Hangoc, G., Cooper, S., Plett, P. A., Liles, W. C., Li, X., Graham-Evans, B., Campbell, T. B., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041385 · Cited by 970 · cited 1×
“To date, interference of CXCL12 action by specific CXCR4 inhibitors has been used primarily for enhancing the yield of HSCs from donors for transplantation into myeloablated patients (71, 72).”
Scharenberg, C. W., Harkey, M. A., & Torok-Storb, B. (2002) · Blood · doi:10.1182/blood.v99.2.507 · Cited by 770 · cited 1×
“The latter property underlies the detection of adult mouse HSCs as side population (SP) cells (10).”
BackgroundCrump, M. P., Gong, J., Loetscher, P., Rajarathnam, K., Amara, A., Arenzana‐Seisdedos, F., Virelizier, J., Baggiolini, M., Sykes, B. D., & Clark‐Lewis, I. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.6996 · Cited by 731 · cited 13×
“In addition, as would be predicted from the explanation we have advanced, forced overexpression of CXCR4 in retrovirally transduced (i.e., proliferating) human HSCs was able to enhance the in vivo engrafting activity of these cells (68), and, conversely, treatment with antibodies to CXCR4 had the opposite effect (69).”
BackgroundInfluentialStier, S., Ko, Y., Forkert, R., Lutz, C., Neuhaus, T., Grünewald, E., Cheng, T., Dombkowski, D., Calvi, L. M., Rittling, S. R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041992 · Cited by 714 · cited 2×
“These include CXC chemokine ligand 12 (CXCL12; also referred to as stromal cell–derived factor 1 [SDF-1]) and CXC chemokine receptor 4 (CXCR4), Steel factor (SF) and c-kit, CD44 and hyaluronic acid or osteopontin, VLA4 and VCAM1, and P2Y-like receptor and an unknown ligand (22–25).”
BackgroundRufer, N., Brümmendorf, T. H., Kolvraa, S., Bischoff, C., Christensen, K., Wadsworth, L., Schulzer, M., & Lansdorp, P. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.2.157 · Cited by 709 · cited 1×
“In humans, an abrupt change in HSC proliferative activity at an analogous point in development (2–4 years) has been inferred from measurements of the rate of decline in telomere length of circulating leukocytes (50).”
BackgroundGuidance of Primordial Germ Cell Migration by the Chemokine SDF-1
Doitsidou, M., Reichman-Fried, M., Stebler, J., Köprunner, M., Dörries, J., Meyer, D., Esguerra, C. V., Leung, T., & Raz, E. (2002) · Cell · doi:10.1016/s0092-8674(02)01135-2 · Cited by 697 · cited 1×
“Such a possibility has, in fact, recently been modeled in the zebrafish, where overexpression of CXCL12 in the germ cells was found to prevent the normal migration of these cells toward endogenous CXCL12 signals (65).”
BackgroundPassegué, E., Wagers, A. J., Giuriato, S., Anderson, W. C., & Weissman, I. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050967 · Cited by 646 · cited 1×
“In association with these changes, some HSCs begin to differentiate and hence permanently lose their long-term repopulating activity, but many do not in spite of their transiently altered phenotype (16).”
BackgroundIkuta, K., & Weissman, I. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1502 · Cited by 636 · cited 1×
“These include genes encoding various transcription factors, i.e., Runx1 (55), Notch (56), Scl (57), bmi1 (58, 59), and Gfi-1 (60, 61), as well as the growth factor receptors c-Kit (62, 63) and Tie2 (64).”
BackgroundThe purification and characterization of fetal liver hematopoietic stem cells
Morrison, S. J., Hemmati, H. D., Wandycz, A. M., & Weissman, I. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10302 · Cited by 611 · cited 2×
“However, when HSCs are activated, they rapidly downregulate expression of CD38 (6, 11), increase expression of CD34 (12) and Mac1 (13, 14), and acquire a Rho bright , non-SP phenotype (15).”
BackgroundMa, Q., Jones, D., & Springer, T. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80046-1 · Cited by 583 · cited 1×
“In the hematopoietic system, it is interesting to note that long-term repopulating CXCL12 –/– HSCs engrafted irradiated hosts, whereas only short-term repopulation was obtained from CXCR4 –/– cells (66, 67).”
BackgroundGfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells
Hock, H., Hamblen, M. J., Rooke, H. M., Schindler, J. W., Saleque, S., Fujiwara, Y., & Orkin, S. H. (2004) · Nature · doi:10.1038/nature02994 · Cited by 541 · cited 1×
“These include genes encoding various transcription factors, i.e., Runx1 (55), Notch (56), Scl (57), bmi1 (58, 59), and Gfi-1 (60, 61), as well as the growth factor receptors c-Kit (62, 63) and Tie2 (64).”
BackgroundHattori, K., Heissig, B., Tashiro, K., Honjo, T., Tateno, M., Shieh, J.-H., Hackett, N. R., Quitoriano, M. S., Crystal, R. G., Rafii, S., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3354 · Cited by 530 · cited 1×
“Previous reports have shown that CXCL12 can promote both the mobilization (36) and the homing (37–39) of HSCs.”
BackgroundAn early pre-liver intraembryonic source of CFU-S in the developing mouse
Medvinsky, A. L., Samoylina, N. L., Müller, A. M., & Dzierzak, E. A. (1993) · Nature · doi:10.1038/364064a0 · Cited by 508 · cited 1×
“In the mouse embryo, pluripotent hematopoietic cells with long-term repopulating ability first appear in the aorta-gonad-meso-nephros region on the ninth day of gestation (28).”
BackgroundDe Clercq, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1134 · Cited by 460 · cited 1×
“SDF-1G2 is thus structurally quite different from AMD3100 but similar in its ability to block CXCL12 from binding to CXCR4 without activating CXCR4 (42, 43).”
BackgroundFlomenberg, N. (2005) · Blood · doi:10.1182/blood-2005-02-0468 · Cited by 460 · cited 1×
“To date, interference of CXCL12 action by specific CXCR4 inhibitors has been used primarily for enhancing the yield of HSCs from donors for transplantation into myeloablated patients (71, 72).”
Lapidot, T., & Kollet, O. (2002) · Leukemia · doi:10.1038/sj.leu.2402684 · Cited by 456 · cited 1×
“Previous reports have shown that CXCL12 can promote both the mobilization (36) and the homing (37–39) of HSCs.”
BackgroundSzilvassy, S. J., Humphries, R. K., Lansdorp, P. M., Eaves, A. C., & Eaves, C. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8736 · Cited by 450 · cited 2×
“HSC numbers can be quantified by endpoints that measure this regenerative activity in genetically distinguishable, radioprotected hosts transplanted with limiting numbers of HSCs (1).”
BackgroundMethodSelf-citationTranscription factor Gfi1 regulates self‐renewal and engraftment of hematopoietic stem cells
Zeng, H., Yücel, R., Kosan, C., Klein‐Hitpass, L., & Möröy, T. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600419 · Cited by 329 · cited 1×
“These include genes encoding various transcription factors, i.e., Runx1 (55), Notch (56), Scl (57), bmi1 (58, 59), and Gfi-1 (60, 61), as well as the growth factor receptors c-Kit (62, 63) and Tie2 (64).”
BackgroundResting and activated subsets of mouse multipotent hematopoietic stem cells.
Spangrude, G. J., & Johnson, G. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7433 · Cited by 313 · cited 1×
“These G 0 HSCs also actively exclude certain fluorescent dyes, such as rhodamine-123 (Rho) (7, 8) and Hoechst 33342 (Hst) (9).”
BackgroundRandall, T. D., & Weissman, I. L. (1997) · Blood · doi:10.1182/blood.v89.10.3596 · Cited by 290 · cited 1×
“To isolate lin – cells from 3-week-old mice, the Mac1 antibody was omitted because Mac1 is known to be expressed on fetal and cycling HSCs (13, 14, 73).”
BackgroundUnexpectedly Efficient Homing Capacity of Purified Murine Hematopoietic Stem Cells
Matsuzaki, Y., Kinjo, K., Mulligan, R. C., & Okano, H. (2004) · Immunity · doi:10.1016/s1074-7613(03)00354-6 · Cited by 290 · cited 1×
“Quiescent adult mouse HSCs can execute this process at near unit efficiency in suitably myelo-suppressed hosts, as shown by their detection at purities of 20% and higher following intravenous injection (15, 17, 18).”
BackgroundInfluentialEaves, C., Cashman, J., Kay, R., Dougherty, G., Otsuka, T., Gaboury, L., Hogge, D., Lansdorp, P., Eaves, A., & Humphries, R. (1991) · Blood · doi:10.1182/blood.v78.1.110.110 · Cited by 281 · cited 1×
“(44, 49) and of elements of the BM microenvironment in vivo (25).”
BackgroundSelf-citationMazurier, F., Doedens, M., Gan, O. I., & Dick, J. E. (2003) · Nature Medicine · doi:10.1038/nm886 · Cited by 281
Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells
Fleming, W., Alpern, E., Uchida, N., Ikuta, K., Spangrude, G., & Weissman, I. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.4.897 · Cited by 277 · cited 1×
“5-dpc FL that are proliferating has been previously estimated from phenotyping studies to be approximately 35% (3), although a more direct measurement of this fraction has not been reported.”
BackgroundWolf, N. S., Koné, A., Priestley, G. V., & Bartelmez, S. (1993) · PubMed · Cited by 257
Glimm, H., Oh, I.-H., & Eaves, C. J. (2000) · Blood · doi:10.1182/blood.v96.13.4185 · Cited by 256
Self-citationA requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development
Hadland, B. K., Huppert, S. S., Kanungo, J., Xue, Y., Jiang, R., Gridley, T., Conlon, R. A., Cheng, A. M., Kopan, R., & Longmore, G. D. (2004) · Blood · doi:10.1182/blood-2004-03-1224 · Cited by 240 · cited 1×
“These include genes encoding various transcription factors, i.e., Runx1 (55), Notch (56), Scl (57), bmi1 (58, 59), and Gfi-1 (60, 61), as well as the growth factor receptors c-Kit (62, 63) and Tie2 (64).”
BackgroundRebel, V., Miller, C., Eaves, C., & Lansdorp, P. (1996) · Blood · doi:10.1182/blood.v87.8.3500.bloodjournal8783500 · Cited by 223 · cited 1×
“Many other differences in the properties of fetal and adult HSCs and the programs they dic-tate have also been described (13, 53, 54).”
BackgroundSelf-citationA cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution
Kawabata, K., Ujikawa, M., Egawa, T., Kawamoto, H., Tachibana, K., Iizasa, H., Katsura, Y., Kishimoto, T., & Nagasawa, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5663 · Cited by 220 · cited 1×
“In the hematopoietic system, it is interesting to note that long-term repopulating CXCL12 –/– HSCs engrafted irradiated hosts, whereas only short-term repopulation was obtained from CXCR4 –/– cells (66, 67).”
BackgroundA molecular profile of a hematopoietic stem cell niche
Hackney, J. A., Charbord, P., Brunk, B. P., Stoeckert, C. J., Lemischka, I. R., & Moore, K. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192124499 · Cited by 215 · cited 1×
“Thus, although differences between BM and FL niches and stromal cells have been sought and described (45–48), these differences do not appear to directly determine the cycling activity of the HSCs they are thought to regulate.”
BackgroundGlimm, H., Oh, I., & Eaves, C. J. (2000) · Blood · doi:10.1182/blood.v96.13.4185.h8004185_4185_4193 · Cited by 215 · cited 1×
“The fact that proliferating human HSCs show the same engraftment defect when they transit S/G 2 /M is noteworthy (20) and underscores the clinical implications of these findings.”
BackgroundSelf-citationThe Fluctuating Phenotype of the Lymphohematopoietic Stem Cell with Cell Cycle Transit
Habibian, H. K., Peters, S. O., Hsieh, C. C., Wuu, J., Vergilis, K., Grimaldi, C. I., Reilly, J., Carlson, J. E., Frimberger, A. E., Stewart, F. M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.393 · Cited by 208 · cited 1×
“However, notable changes in HSC engrafting potential have also been found to accompany the progression of HSCs through the cell cycle both in vitro and in vivo (3, 19–21).”
BackgroundGöthert, J. R., Gustin, S. E., Hall, M. A., Green, A. R., Göttgens, B., Izon, D. J., & Begley, C. G. (2005) · Blood · doi:10.1182/blood-2004-08-3037 · Cited by 203 · cited 1×
“These cells then migrate to the fetal liver (FL) and later to the BM, their numbers continually expanding until young adulthood is reached (29).”
BackgroundGlimm, H., Eisterer, W., Lee, K., Cashman, J., Holyoake, T. L., Nicolini, F., Shultz, L. D., von Kalle, C., & Eaves, C. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11519 · Cited by 201 · cited 1×
“In contrast, cells with short-term repopulating activity (8 weeks) were readily detected in the S/G 2 /M fraction as well as in the G 1 fraction, thus confirming the restriction of this cell cycle–dependent engrafting defect to cells with sustained multilineage repopulating activity (34, 35).”
BackgroundSelf-citationBertoncello, I., Hodgson, G., & Tr, B. (1985) · PubMed · Cited by 193
SCL: From the origin of hematopoiesis to stem cells and leukemia
Lécuyer, É., & Hoang, T. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2003.10.010 · Cited by 193 · cited 1×
“These include genes encoding various transcription factors, i.e., Runx1 (55), Notch (56), Scl (57), bmi1 (58, 59), and Gfi-1 (60, 61), as well as the growth factor receptors c-Kit (62, 63) and Tie2 (64).”
BackgroundTurnover and Proliferation of NK Cells in Steady State and Lymphopenic Conditions
Jamieson, A. M., Isnard, P., Dorfman, J. R., Coles, M. C., & Raulet, D. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.864 · Cited by 180 · cited 1×
“These changes include the initial acquisition of an SP and Rho dull phenotype by HSCs (15) and the completion of appearance and rapid cycling of adult-type (Ly49 + ) natural killer cells and peripheral T cells (51, 52).”
BackgroundAcquisition of Ly49 Receptor Expression by Developing Natural Killer Cells
Dorfman, J. R., & Raulet, D. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.609 · Cited by 165 · cited 1×
“These changes include the initial acquisition of an SP and Rho dull phenotype by HSCs (15) and the completion of appearance and rapid cycling of adult-type (Ly49 + ) natural killer cells and peripheral T cells (51, 52).”
BackgroundPawliuk, R., Eaves, C., & Humphries, R. (1996) · Blood · doi:10.1182/blood.v88.8.2852.bloodjournal8882852 · Cited by 158 · cited 1×
“Many other differences in the properties of fetal and adult HSCs and the programs they dic-tate have also been described (13, 53, 54).”
BackgroundSelf-citationHematopoietic stem cells engraft in mice with absolute efficiency
Benveniste, P. M., Cantin, C., Hyam, D., & Iscove, N. N. (2003) · Nature Immunology · doi:10.1038/ni940 · Cited by 141 · cited 1×
“Quiescent adult mouse HSCs can execute this process at near unit efficiency in suitably myelo-suppressed hosts, as shown by their detection at purities of 20% and higher following intravenous injection (15, 17, 18).”
BackgroundInfluentialCashman, J. D., Clark‐Lewis, I., Eaves, A. C., & Eaves, C. J. (2002) · Blood · doi:10.1182/blood.v99.3.792 · Cited by 139 · cited 2×
“(44, 49) and of elements of the BM microenvironment in vivo (25).”
BackgroundSelf-citationRequirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis
Puri, M. C., & Bernstein, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2133552100 · Cited by 136 · cited 1×
“These include genes encoding various transcription factors, i.e., Runx1 (55), Notch (56), Scl (57), bmi1 (58, 59), and Gfi-1 (60, 61), as well as the growth factor receptors c-Kit (62, 63) and Tie2 (64).”
BackgroundExpression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cells
Randall, T., Lund, F., Howard, M., & Weissman, I. (1996) · Blood · doi:10.1182/blood.v87.10.4057.bloodjournal87104057 · Cited by 135 · cited 3×
“However, when HSCs are activated, they rapidly downregulate expression of CD38 (6, 11), increase expression of CD34 (12) and Mac1 (13, 14), and acquire a Rho bright , non-SP phenotype (15).”
BackgroundInfluentialOrschell-Traycoff, C. M., Hiatt, K., Dagher, R. N., Rice, S., Yoder, M. C., & Srour, E. F. (2000) · Blood · doi:10.1182/blood.v96.4.1380 · Cited by 133
Adhesion receptor expression by hematopoietic cell lines and murine progenitors
Becker, P. S., Nilsson, S. K., Li, Z., Berrios, V. M., Dooner, M. S., Cooper, C. L., Hsieh, C., & Quesenberry, P. J. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(98)00037-x · Cited by 132 · cited 1×
“The expression and activity of some of these appear to be variably affected by cytokine exposure (26, 27); however, their specific involvement in the engraftment defect of HSCs in S/G 2 /M has remained unclear.”
BackgroundUchida, N., Dykstra, B. J., Lyons, K., Leung, F. Y. K., & Eaves, C. J. (2003) · Experimental Hematology · doi:10.1016/j.exphem.2003.09.001 · Cited by 127 · cited 1×
“Sixteen hours was anticipated to be sufficient to allow all cycling HSCs to enter S-phase, which we later confirmed (see below), with minimal exit of any quiescent cells from G0 (31), as demonstrated for adult BM HSCs, most of which were in G0 (Figure 1A).”
BackgroundSelf-citationBrenner, S., Whiting‐Theobald, N., Kawai, T., Linton, G. F., Rudikoff, A. G., Choi, U., Ryser, M., Murphy, P. M., Sechler, J. M. G., & Malech, H. L. (2004) · Stem Cells · doi:10.1634/stemcells.2003-0196 · Cited by 126 · cited 1×
“…be predicted from the explanation we have advanced, forced overexpression of CXCR4 in retrovirally transduced (i.e., proliferating) human HSCs was able to enhance the in vivo engrafting activity of these cells (68), and, conversely, treatment with antibodies to CXCR4 had the opposite effect (69).”
BackgroundFukuda, S., Broxmeyer, H. E., & Pelus, L. M. (2004) · Blood · doi:10.1182/blood-2004-04-1440 · Cited by 126
RUNX1/AML1: A Central Player in Hematopoiesis
Okuda, T., Nishimura, M., Nakao, M., & Fujitaa, Y. (2001) · International Journal of Hematology · doi:10.1007/bf02982057 · Cited by 118 · cited 1×
“These include genes encoding various transcription factors, i.e., Runx1 (55), Notch (56), Scl (57), bmi1 (58, 59), and Gfi-1 (60, 61), as well as the growth factor receptors c-Kit (62, 63) and Tie2 (64).”
BackgroundRebel, V. I., Miller, C., Thornbury, G., Dragowska, W. H., Eaves, C. J., & Lansdorp, P. M. (1996) · PubMed · Cited by 116
Self-citationLee, B.-C., Cheng, T., Adams, G. B., Attar, E. C., Miura, N., Lee, S. B., Saito, Y., Olszak, I. T., Dombkowski, D., Olson, D. P., et al. (2003) · Genes & Development · doi:10.1101/gad.1071503 · Cited by 101
Microenvironmental regulation of hematopoietic stem cells
Lemischka, I. R. (1997) · Stem Cells · doi:10.1002/stem.5530150810 · Cited by 99
Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines
Bonig, H. B., Priestley, G. V., & Papayannopoulou, T. (2005) · Blood · doi:10.1182/blood-2005-05-2023 · Cited by 92 · cited 1×
“The expression and activity of some of these appear to be variably affected by cytokine exposure (26, 27); however, their specific involvement in the engraftment defect of HSCs in S/G 2 /M has remained unclear.”
BackgroundLeemhuis, T., Yöder, M. C., Grigsby, S., Agüero, B., Eder, P., & Srour, E. F. (1996) · PubMed · Cited by 87
Ponchio, L., Conneally, E., & Eaves, C. J. (1995) · Blood · doi:10.1182/blood.v86.9.3314.bloodjournal8693314 · Cited by 86 · cited 10×
“( B ) The effects of 3 H-Tdr on 18.5-dpc fetal BM (FBM) and FL CRUs (left and right panels; data pooled from 4 independent experiments).”
MethodInfluentialSelf-citationA role for niches in hematopoietic cell development
Heissig, B., Ohki, Y., Sato, Y., Rafii, S., Werb, Z., & Hattori, K. (2005) · Hematology · doi:10.1080/10245330500067249 · Cited by 86
Potential Clinical Applications of the CXCR4 Antagonist Bicyclam AMD3100
De Clercq, E. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557054867075 · Cited by 86 · cited 1×
“However, the mobilization of primitive hematopoietic cells can also be stimulated by blocking CXCL12/CXCR4 signaling, as achieved by in vivo administration of AMD3100, a CXCL12 antagonist (40).”
BackgroundReciprocal expression of CD38 and CD34 by adult murine hematopoietic stem cells
Tajima, F., Deguchi, T., Laver, J. H., Zeng, H., & Ogawa, M. (2001) · Blood · doi:10.1182/blood.v97.9.2618 · Cited by 84 · cited 1×
“However, when HSCs are activated, they rapidly downregulate expression of CD38 (6, 11), increase expression of CD34 (12) and Mac1 (13, 14), and acquire a Rho bright , non-SP phenotype (15).”
BackgroundLadd, A. C., Pyatt, R., Gothot, A., Rice, S., McMahel, J., Traycoff, C. M., & Srour, E. F. (1997) · Blood · doi:10.1182/blood.v90.2.658 · Cited by 83
Mobilization as a preparative regimen for hematopoietic stem cell transplantation
Chen, J., Larochelle, A., Fricker, S. P., Bridger, G. J., Dunbar, C. E., & Abkowitz, J. L. (2006) · Blood · doi:10.1182/blood-2005-09-3593 · Cited by 78 · cited 2×
“Recently, Chen et al. (41) found that administration of AMD3100 pretransplant can produce a modest improvement in the engraftment of quiescent adult BM HSCs transplanted into nonirradiated hosts.”
BackgroundMiller, C. L., Rebel, V. I., Helgason, C. D., Lansdorp, P. M., & Eaves, C. J. (1997) · Blood · doi:10.1182/blood.v89.4.1214 · Cited by 74 · cited 1×
“These include genes encoding various transcription factors, i.e., Runx1 (55), Notch (56), Scl (57), bmi1 (58, 59), and Gfi-1 (60, 61), as well as the growth factor receptors c-Kit (62, 63) and Tie2 (64).”
BackgroundSelf-citationUchida, N., Dykstra, B. J., Lyons, K. J., Leung, F. Y. K., Kristiansen, M., & Eaves, C. J. (2004) · Blood · doi:10.1182/blood-2003-11-3989 · Cited by 71 · cited 3×
“However, when HSCs are activated, they rapidly downregulate expression of CD38 (6, 11), increase expression of CD34 (12) and Mac1 (13, 14), and acquire a Rho bright , non-SP phenotype (15).”
BackgroundInfluentialSelf-citationTajima, F., Sato, T., Laver, J. H., & Ogawa, M. (2000) · Blood · doi:10.1182/blood.v96.5.1989 · Cited by 63 · cited 3×
“However, when HSCs are activated, they rapidly downregulate expression of CD38 (6, 11), increase expression of CD34 (12) and Mac1 (13, 14), and acquire a Rho bright , non-SP phenotype (15).”
BackgroundInfluentialSzilvassy, S. J., Meyerrose, T. E., & Grimes, B. A. (2000) · Blood · doi:10.1182/blood.v95.9.2829.009k37_2829_2837 · Cited by 61 · cited 1×
“In contrast, cells with short-term repopulating activity (8 weeks) were readily detected in the S/G 2 /M fraction as well as in the G 1 fraction, thus confirming the restriction of this cell cycle–dependent engrafting defect to cells with sustained multilineage repopulating activity (34, 35).”
BackgroundRecent advances in defining the hematopoietic stem cell niche
Moore, K. A. (2004) · Current Opinion in Hematology · doi:10.1097/01.moh.0000133652.06863.47 · Cited by 58 · cited 1×
“Thus, although differences between BM and FL niches and stromal cells have been sought and described (45–48), these differences do not appear to directly determine the cycling activity of the HSCs they are thought to regulate.”
BackgroundCashman, J., Dykstra, B., Clark-Lewis, I., Eaves, A., & Eaves, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010916 · Cited by 53 · cited 1×
“Previous reports have shown that CXCL12 can promote both the mobilization (36) and the homing (37–39) of HSCs.”
BackgroundSelf-citationThe marrow homing efficiency of murine hematopoietic stem cells remains constant during ontogeny
Szilvassy, S. J., Ragland, P. L., Miller, C., & Eaves, C. J. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00005-5 · Cited by 52
Self-citationRandall, T. D., & Weissman, I. L. (1997) · Blood · doi:10.1182/blood.v89.10.3596.3596_3596_3606 · Cited by 33
Harrison, D. E., Astle, C. M., & Lerner, C. P. (1984) · The Journal of Experimental Medicine · doi:10.1084/jem.160.3.759 · Cited by 29 · cited 1×
“Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0).”
BackgroundSzilvassy, S. J., Nicolini, F. E., Eaves, C. J., & Miller, C. L. (2003) · Hematopoietic Stem Cell Protocols · doi:10.1385/1-59259-140-x:167 · Cited by 25
Self-citationEaves, C., Cashman, J., Kay, R., et al. (1991) · Blood · doi:10.1182/blood.v78.1.110.bloodjournal781110 · Cited by 17
Self-citationGöthert, J. R., Gustin, S. E., Hall, M. A., Green, A. R., Göttgens, B., Izon, D. J., & Begley, C. G. (2004) · Blood · doi:10.1182/blood.v104.11.559.559 · Cited by 15
Ladd, A. C., Pyatt, R. E., Gothot, A., et al. (1997) · Blood · doi:10.1182/blood.v90.2.658.658_658_668 · Cited by 10 · cited 1×
“These subsets were isolated by fluorescence-activated cell sorting (FACS) on the basis of their staining with Hst and Pyronin Y (Py) (32).”
MethodTajima, F., Sato, T., Laver, J. H., et al. (2000) · Blood · doi:10.1182/blood.v96.5.1989.h8001989_1989_1993 · Cited by 5
Orschell-Traycoff, C. M., Hiatt, K. K., Dagher, R. N., et al. (2000) · Blood · doi:10.1182/blood.v96.4.1380.h8001380_1380_1387 · Cited by 5 · cited 1×
“However, notable changes in HSC engrafting potential have also been found to accompany the progression of HSCs through the cell cycle both in vitro and in vivo (3, 19–21).”
Background
Cited by
Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C. F., Eshkind, L., Bockamp, E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.048 · Cited by 1,908
“Our identification of a dormant population with high stem cell activity in adult mice extends recent studies showing that HSCs undergo a sudden switch from a predominantly proliferative fetal liver and postnatal HSC compartment to a more quiescent one 4 weeks after birth ( Bowie et al., 2006, 2007 ).”
Stems Cells and the Pathways to Aging and Cancer
Rossi, D. J., Jamieson, C. H. M., & Weissman, I. L. (2008) · Cell · doi:10.1016/j.cell.2008.01.036 · Cited by 895
“, 1997), cell-cycle status (Bowie et al., 2006), and the anatomical location where stem cell activity resides (see Review by S.”
BackgroundNo place like home: anatomy and function of the stem cell niche
Jones, D. L., & Wagers, A. J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2319 · Cited by 797
“Fetal and adult HSCs also exhibit striking differences in their cell surface marker expression and proliferative activit”
BackgroundChen, C., Liu, Y., Liu, R., Ikenoue, T., Guan, K.-L., Liu, Y., & Zheng, P. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081297 · Cited by 682
Decoding human fetal liver haematopoiesis
Popescu, D.-M., Botting, R. A., Stephenson, E., Green, K., Webb, S., Jardine, L., Calderbank, E. F., Polanski, K., Goh, I., Efremova, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1652-y · Cited by 606
Metadata
- Authors
- Bowie, M. B., McKnight, K. D., Kent, D. G., McCaffrey, L., Hoodless, P. A., & Eaves, C. J.
- Affiliations
- BC Cancer Agency (CA)
- Corresponding author
- Eaves, C. J.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-10-02
- Volume
- 116
- Issue
- 10
- Pages
- 2808-2816
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1578623
- OpenAlex
- W2052350491
- Cited by
- 380
- References
- 79
- Citations by year
- 2026: 7 · 2025: 22 · 2024: 16 · 2023: 22 · 2022: 18 · 2021: 26 · 2020: 20 · 2019: 9 · 2018: 17 · 2017: 17 · 2016: 24 · 2015: 18 · 2014: 24 · 2013: 15 · 2012: 18
- FWCI
- 13.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Stem Cell Network
- Michael Smith Health Research BC
- Terry Fox Foundation
- National Institutes of Health
- Canadian Institutes of Health Research
- National Heart, Lung, and Blood Institute (P01HL055435, P01 HL 55435)
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- hematopoietic stem cells, HSC proliferation, HSC quiescence, cell cycle, S/G2/M phase, CXCL12, hematopoietic ontogeny, bone marrow transplantation
- MeSH terms
- Animals, Animals, Newborn, Bone Marrow Cells, Cell Cycle, Fluorouracil, Graft Survival, Hematopoiesis, Hematopoietic Stem Cells, Hematopoietic System, Liver, Mice, Inbred C57BL, Thymidine, Gene Expression, Hematopoietic Stem Cell Transplantation, Hyaluronan Receptors, Proto-Oncogene Proteins c-kit, Vascular Cell Adhesion Molecule-1, Receptors, CXCR4, Chemokines, CXC, Integrin alpha4, Cell Proliferation, Mice, Chemokine CXCL12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.